Catalyst Wire Dossier Catalyst Wire Dossier

ADX10059

· Addex Pharma S.A.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ADX10059, covering 2009-12-24 to 2012-07-16. Get the full timeline:

Most recent: Clinical Trial Update: ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD) [Phase 2]

See pricing